WellDoc's new president embraces mobile health with innovative platform

By Admin
Written by Alyssa Clark While preparing to introduce its latest improvements to the youngest addition of the WellDoc app family, the organization has...

Written by Alyssa Clark

 

While preparing to introduce its latest improvements to the youngest addition of the WellDoc app family, the organization has implemented new president Kevin McRaith. WellDoc is embracing this seasoned bio-tech veteran due to his mhealth-oriented agenda; as the company finalizes preparations to roll out final touches to the highly-anticipated Bluestar platform this year. This platform is an FDA-approved mobile health application that is bent on improving patient engagement for people with Type 2 Diabetes.

The organization has already earned quite a bit of publicity for its recent accomplishments:

“In the run-up to commercialization of Bluestar later this year, WellDoc raised a $20 million Series A round led by the Merck Global Health Innovation Fund. In 2013, it launched a mobile diabetes intervention tool for physicians. Bluestar gives users real-time feedback based on the user’s personal health data in areas such as medications, blood sugar readings, diet and exercise. It also provides content to boost users’ health literacy and motivational support,” reports the New York Times.

Current WellDoc president Dr. Anand Iyer will take a new role as chief data science officer, which will boost the company’s analytics engine, according to a company-released statement.

With over 20 years of biotech industry experience and several product launches, Kevin McRaith’s recent hire demonstrates the industry-wide marriage between the pharmaceutical and mhealth worlds; an arrangement which has currently polarized industry experts in a heated debate. This hire also presents an interesting demonstration of these highly-debated market trends; by analyzing the meeting of these two different industries through McRaith’s acquisition, analysts suggest that the future of mobile technology within healthcare will be one where physicians prescribe just as many apps as they do medications.

 “Although the app is already in the market, available through employer plans at companies such as Ford and RiteAid, the hire reflects a bigger sales and marketing push by the mobile health company.”

 



 

Share
Share

Featured Articles

Healthcare staff shortage creates cyber security risk

The healthcare industry is chronically understaffed which is exacerbating cyber security risk, says SailPoint’s Steve Bradford, in new research report

Philip Morris International (PMI) in agreement with KT&G

PMI and KT&G are building a smoke-free world. In a new agreement between the two companies, smoke-free alternatives are within reach for smokers

Health tech leader Philips shares sustainability ambition

Roy Jakobs, Royal Philips CEO, says the health technology company’s sustainability impact plan will ‘enhance accountability & strengthen talent’

Automating gene therapy & pharma discovery at Automata

Medical Devices & Pharma

Itai Hayut, CEO of Scopio Labs, on AI & blood cancer

Technology & AI

2023 predictions with Harshit Jain, global CEO of Doceree

Telehealth & COVID-19